Laparoscopic splenectomy for non-traumatic diseases

Area of Science:

• Minimally Invasive Surgery
• Gastrointestinal Surgery
• Surgical Oncology

Background:

• Laparoscopic splenectomy (LS) is the gold standard for benign hematologic diseases with normal-sized spleens.
• Advancements demonstrate LS feasibility and safety in massive splenomegaly, malignant conditions, and traumatic splenic injuries.
• LS is an advanced procedure requiring a multidisciplinary team approach for optimal patient outcomes.

Purpose of the Study:

• To review the evolving techniques and indications for laparoscopic splenectomy.
• To highlight the importance of preoperative assessment and surgical strategy in LS.
• To compare the benefits of LS versus open splenectomy.

Main Methods:

• Review of current literature and surgical approaches for LS.
• Analysis of preoperative factors influencing surgical strategy.
• Discussion of various surgical techniques (anterior, semilateral, lateral, hand-assisted) and new surgical tools.

Main Results:

• LS is feasible and safe for a broader range of conditions than previously thought.
• Preoperative evaluation and tailored surgical strategy are crucial for successful LS.
• Evidence suggests LS leads to less surgical trauma, reduced blood loss, and quicker recovery.

Conclusions:

• Laparoscopic splenectomy offers significant advantages over open surgery, including reduced patient morbidity and improved cosmesis.
• The technique is adaptable to complex cases, demanding careful preoperative planning and surgical expertise.
• Continued evolution of LS techniques and tools enhances its application in diverse clinical scenarios.